We are flat with a downward bias a half-hour before the market opens this Tuesday, with more earnings results reporting ...
Jefferies analyst Akash Tewari maintained a Buy rating on Pfizer (PFE – Research Report) today and set a price target of $33.00. The company’s ...
Stocks are struggling for direction today, and one sector that represents this choppiness is blue-chip drugmakers. Merck & Co ...
Pfizer PFE announced positive top-line results from the progression-free survival (PFS) analysis of a late-stage study of its ...
U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by cost-cutting efforts and ...
Pfizer (PFE) is set to announce Q4 earnings, with analysts expecting a $0.46 profit per share and $17.26B revenue.
Analysts expect the New York-based company to report quarterly earnings at 46 cents per share, up from 10 cents per share in ...
CEO Albert Bourla told investors Tuesday morning that he is “cautiously optimistic” about working with Robert F. Kennedy Jr., ...